메뉴 건너뛰기




Volumn 27, Issue 2, 2009, Pages 312-313

Small molecule tyrosine kinase inhibitor and depression

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLONAZEPAM; DASATINIB; DESIPRAMINE; IMATINIB; METHYLPHENIDATE; MIRTAZAPINE; NORTRIPTYLINE; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB; TRAZODONE; VENLAFAXINE; ANTINEOPLASTIC AGENT; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

EID: 58249089751     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.7236     Document Type: Letter
Times cited : (13)

References (3)
  • 1
    • 39349113732 scopus 로고    scopus 로고
    • Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III trial ACOSOG Z9001
    • Presented at the, June 1-5, Chicago, IL abstr 10079
    • DeMatteo R, Owzar K, Maki R, et al: Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III trial ACOSOG Z9001. Presented at the 43rd Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2007, Chicago, IL (abstr 10079)
    • (2007) 43rd Annual Meeting of the American Society of Clinical Oncology
    • DeMatteo, R.1    Owzar, K.2    Maki, R.3
  • 2
    • 0018339437 scopus 로고
    • Risk of suicide among cancer patients
    • Louhivuori KA, Hakama M: Risk of suicide among cancer patients. Am J Epidemiol 109:59-65, 1979
    • (1979) Am J Epidemiol , vol.109 , pp. 59-65
    • Louhivuori, K.A.1    Hakama, M.2
  • 3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.